Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Net Tangible Assets

The latest net tangible assets for DMAQR is $2.1M as of June 2026. That compares with $4.3M in the prior-year period — down 52.2% year over year. Investors often review this figure alongside Deep Medicine Acquisition - Tradeable Rights - Oct 2026's historical trend and sector peers before judging valuation or financial health.

Over the past year, DMAQR's net tangible assets moved from $4.3M to $2.1M — a 52.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Deep Medicine Acquisition - Tradeable Rights - Oct 2026's operating scale or balance-sheet position.

A net tangible assets figure of $2.1M for DMAQR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMAQR's net tangible assets ($2.1M), review year-over-year change from $4.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.